Full text
PDFPage 126
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bikkina M., Alpert M. A., Mulekar M., Shakoor A., Massey C. V., Covin F. A. Prevalence of intraatrial thrombus in patients with atrial flutter. Am J Cardiol. 1995 Jul 15;76(3):186–189. doi: 10.1016/s0002-9149(99)80058-7. [DOI] [PubMed] [Google Scholar]
- Black I. W., Fatkin D., Sagar K. B., Khandheria B. K., Leung D. Y., Galloway J. M., Feneley M. P., Walsh W. F., Grimm R. A., Stollberger C. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation. 1994 Jun;89(6):2509–2513. doi: 10.1161/01.cir.89.6.2509. [DOI] [PubMed] [Google Scholar]
- Black I. W., Hopkins A. P., Lee L. C., Walsh W. F. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J. 1993 Aug;126(2):375–381. doi: 10.1016/0002-8703(93)91054-i. [DOI] [PubMed] [Google Scholar]
- Dalzell G. W., Anderson J., Adgey A. A. Factors determining success and energy requirements for cardioversion of atrial fibrillation: revised version. Q J Med. 1991 Jan;78(285):85–95. [PubMed] [Google Scholar]
- Falk R. H., Knowlton A. A., Bernard S. A., Gotlieb N. E., Battinelli N. J. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med. 1987 Apr;106(4):503–506. doi: 10.7326/0003-4819-106-4-503. [DOI] [PubMed] [Google Scholar]
- Falk R. H., Leavitt J. I. Digoxin for atrial fibrillation: a drug whose time has gone? Ann Intern Med. 1991 Apr 1;114(7):573–575. doi: 10.7326/0003-4819-114-7-573. [DOI] [PubMed] [Google Scholar]
- Hamer A. W., Arkles L. B., Johns J. A. Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. J Am Coll Cardiol. 1989 Dec;14(7):1768–1774. doi: 10.1016/0735-1097(89)90030-2. [DOI] [PubMed] [Google Scholar]
- Kannel W. B., Abbott R. D., Savage D. D., McNamara P. M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982 Apr 29;306(17):1018–1022. doi: 10.1056/NEJM198204293061703. [DOI] [PubMed] [Google Scholar]
- Krahn A. D., Manfreda J., Tate R. B., Mathewson F. A., Cuddy T. E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995 May;98(5):476–484. doi: 10.1016/S0002-9343(99)80348-9. [DOI] [PubMed] [Google Scholar]
- Lip G. Y. Cardioversion of atrial fibrillation. Postgrad Med J. 1995 Aug;71(838):457–465. doi: 10.1136/pgmj.71.838.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Uretsky B. F., Young J. B., Shahidi F. E., Yellen L. G., Harrison M. C., Jolly M. K. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993 Oct;22(4):955–962. doi: 10.1016/0735-1097(93)90403-n. [DOI] [PubMed] [Google Scholar]
- Van Gelder I. C., Crijns H. J., Blanksma P. K., Landsman M. L., Posma J. L., Van Den Berg M. P., Meijler F. L., Lie K. I. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol. 1993 Sep 1;72(7):560–566. doi: 10.1016/0002-9149(93)90352-d. [DOI] [PubMed] [Google Scholar]
- Yacoub M. H. Two hearts that beat as one. Circulation. 1995 Jul 15;92(2):156–157. doi: 10.1161/01.cir.92.2.156. [DOI] [PubMed] [Google Scholar]